A novel approach to screening for new neuroprotective compounds for the treatment of stroke

[1]  P. Lapchak.  The phenylpropanoid micronutrient chlorogenic acid improves clinical rating scores in rabbits following multiple infarct ischemic strokes: Synergism with tissue plasminogen activator , 2007, Experimental Neurology.

[2]  P. Lapchak,et al.  Advances in ischemic stroke treatment: neuroprotective and combination therapies , 2007, Expert opinion on emerging drugs.

[3]  K. Arai,et al.  Baicalein and 12/15-Lipoxygenase in the Ischemic Brain , 2006, Stroke.

[4]  K. Abe,et al.  Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory , 2006, Proceedings of the National Academy of Sciences.

[5]  R. Andriantsitohaina,et al.  Cellular mechanisms of the protective effect of polyphenols on the neurovascular unit in strokes. , 2006, Cardiovascular & hematological agents in medicinal chemistry.

[6]  A. Shuaib,et al.  Therapeutic strategies for the treatment of stroke. , 2006, Drug discovery today.

[7]  P. Maher,et al.  Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death. , 2006, Investigative ophthalmology & visual science.

[8]  P. Maher.  A comparison of the neurotrophic activities of the flavonoid fisetin and some of its derivatives , 2006, Free radical research.

[9]  P. Maher,et al.  Flavonoids protect retinal ganglion cells from oxidative stress-induced death. , 2005, Investigative ophthalmology & visual science.

[10]  T. Murphy,et al.  A Small-Molecule-Inducible Nrf2-Mediated Antioxidant Response Provides Effective Prophylaxis against Cerebral Ischemia In Vivo , 2005, The Journal of Neuroscience.

[11]  Paul E Milbury,et al.  Flavonols, flavones, flavanones, and human health: epidemiological evidence. , 2005, Journal of medicinal food.

[12]  M. Plotkine,et al.  Antioxidant strategies in the treatment of stroke. , 2005, Free radical biology & medicine.

[13]  P. Maher.  The effects of stress and aging on glutathione metabolism , 2005, Ageing Research Reviews.

[14]  P. Maher,et al.  The molecular basis of oxidative stress-induced cell death in an immortalized retinal ganglion cell line. , 2005, Investigative ophthalmology & visual science.

[15]  Henry Jay Forman,et al.  Human glutamate cysteine ligase gene regulation through the electrophile response element. , 2004, Free radical biology & medicine.

[16]  P. Maher,et al.  Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal‐regulated kinase activation , 2004, Journal of neurochemistry.

[17]  N. Knuckey,et al.  The protective effect of hypoxic preconditioning on cortical neuronal cultures is associated with increases in the activity of several antioxidant enzymes , 2004, Brain Research.

[18]  P. Lapchak,et al.  Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores , 2004, Experimental Neurology.

[19]  P. Lapchak,et al.  Transcranial Infrared Laser Therapy Improves Clinical Rating Scores After Embolic Strokes in Rabbits , 2004, Stroke.

[20]  P. Lapchak,et al.  Comparison of Tenecteplase with Alteplase on clinical rating scores following small clot embolic strokes in rabbits , 2004, Experimental Neurology.

[21]  P. Eriksson,et al.  Glutathione monoethyl ester provides neuroprotection in a rat model of stroke , 2004, Neuroscience Letters.

[22]  C. B. Pickett,et al.  Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. , 2003, Annual review of pharmacology and toxicology.

[23]  Yael Bromberg,et al.  Reactive oxygen species play an important role in iodoacetate-induced neurotoxicity in primary rat neuronal cultures and in differentiated PC12 cells , 2003, Neuroscience Letters.

[24]  N. Knuckey,et al.  Primary cortical neuronal cultures reduce cellular energy utilization during anoxic energy deprivation , 2003, Journal of neurochemistry.

[25]  P. Lapchak,et al.  Ebselen, a Seleno-Organic Antioxidant, Is Neuroprotective After Embolic Strokes in Rabbits: Synergism With Low-Dose Tissue Plasminogen Activator , 2003, Stroke.

[26]  B. S. Winkler,et al.  Modulation of the Pasteur effect in retinal cells: implications for understanding compensatory metabolic mechanisms. , 2003, Experimental eye research.

[27]  P. Lapchak.  Development of thrombolytic therapy for stroke: a perspective , 2002, Expert opinion on investigational drugs.

[28]  Kelly E Heim,et al.  Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. , 2002, The Journal of nutritional biochemistry.

[29]  P. Lapchak,et al.  Neuroprotective Effects of the Spin Trap Agent Disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-Oxide (Generic NXY-059) in a Rabbit Small Clot Embolic Stroke Model: Combination Studies With the Thrombolytic Tissue Plasminogen Activator , 2002, Stroke.

[30]  N. Sims,et al.  The effects of focal ischemia and reperfusion on the glutathione content of mitochondria from rat brain subregions , 2002, Journal of neurochemistry.

[31]  H. Carlsen,et al.  Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter. , 2002, Free radical biology & medicine.

[32]  P. Maher,et al.  Oxytosis: A novel form of programmed cell death. , 2001, Current topics in medicinal chemistry.

[33]  D. Hou,et al.  Fisetin induces transcription of NADPH:quinone oxidoreductase gene through an antioxidant responsive element-involved activation. , 2001, International journal of oncology.

[34]  Y. Sagara,et al.  Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. , 2001, Free radical biology & medicine.

[35]  J. Kepa,et al.  Induction of human NAD(P)H:quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin. , 2001, Toxicology letters.

[36]  I. Gozes,et al.  VIP-related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells , 2000, Journal of Molecular Neuroscience.

[37]  E. Middleton,et al.  The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. , 2000, Pharmacological reviews.

[38]  C. Kim,et al.  Reduced glutathione oxidation ratio and 8 ohdG accumulation by mild ischemic pretreatment , 2000, Brain Research.

[39]  J. Hayes,et al.  Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. , 1999, Free radical research.

[40]  C. Oliveira,et al.  Distinct Glycolysis Inhibitors Determine Retinal Cell Sensitivity to Glutamate-Mediated Injury , 1999, Neurochemical Research.

[41]  P. Lipton,et al.  Ischemic cell death in brain neurons. , 1999, Physiological reviews.

[42]  C. Shaw,et al.  Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death , 1997, Brain Research Reviews.

[43]  A. Reshef,et al.  Activation and inhibition of protein kinase C protect rat neuronal cultures against ischemia-reperfusion insult , 1997, Neuroscience Letters.

[44]  P. Maher,et al.  The Role of Monoamine Metabolism in Oxidative Glutamate Toxicity , 1996, The Journal of Neuroscience.

[45]  M. Moskowitz,et al.  Emerging treatments for stroke in humans. , 1996, Trends in pharmacological sciences.

[46]  W. Mathews,et al.  The mechanism of cytoprotective action of lazaroids I: Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion. , 1996, The Journal of pharmacology and experimental therapeutics.

[47]  R. Ma.  Flavonoids: naturally occurring anti-inflammatory agents. , 1995, The American journal of pathology.

[48]  P. Maher,et al.  Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line , 1994, Brain Research.

[49]  J. Zivin,et al.  Quantal Bioassay and Stroke , 1992, Stroke.

[50]  P. Reiner,et al.  A pharmacological model of ischemia in the hippocampal slice , 1990, Neuroscience Letters.

[51]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[52]  M. Hansen,et al.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.

[53]  Waud Dr.  ON BIOLOGICAL ASSAYS INVOLVING QUANTAL RESPONSES , 1972 .

[54]  T. Ingall.  Stroke--incidence, mortality, morbidity and risk. , 2004, Journal of insurance medicine.

[55]  F. Dajas,et al.  Some aspects of the in vivo neuroprotective capacity of flavonoids: bioavailability and structure-activity relationship. , 2004, Neurotoxicity research.

[56]  P. Lapchak.  Hemorrhagic transformation following ischemic stroke: Significance, causes, and relationship to therapy and treatment , 2002, Current neurology and neuroscience reports.

[57]  J. Ross,et al.  Dietary flavonoids: bioavailability, metabolic effects, and safety. , 2002, Annual review of nutrition.

[58]  M. Inouye,et al.  Overexpression of human glutathione peroxidase protects transgenic mice against focal cerebral ischemia/reperfusion damage. , 1998, Brain research. Molecular brain research.

[59]  M. Read.  Flavonoids: naturally occurring anti-inflammatory agents. , 1995, The American journal of pathology.

[60]  Lyden Pd,et al.  Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. , 1993, Cerebrovascular and brain metabolism reviews.

[61]  P. Lyden,et al.  Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. , 1993, Cerebrovascular and brain metabolism reviews.

[62]  D. Waud.  On biological assays involving quantal responses. , 1972, The Journal of pharmacology and experimental therapeutics.